247 related articles for article (PubMed ID: 15831474)
1. Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases.
Schmidt-Arras DE; Böhmer A; Markova B; Choudhary C; Serve H; Böhmer FD
Mol Cell Biol; 2005 May; 25(9):3690-703. PubMed ID: 15831474
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain.
Kiyoi H; Ohno R; Ueda R; Saito H; Naoe T
Oncogene; 2002 Apr; 21(16):2555-63. PubMed ID: 11971190
[TBL] [Abstract][Full Text] [Related]
3. FLT-3: a new focus in the understanding of acute leukemia.
Markovic A; MacKenzie KL; Lock RB
Int J Biochem Cell Biol; 2005 Jun; 37(6):1168-72. PubMed ID: 15778081
[TBL] [Abstract][Full Text] [Related]
4. Abnormal localization and accumulation of FLT3-ITD, a mutant receptor tyrosine kinase involved in leukemogenesis.
Koch S; Jacobi A; Ryser M; Ehninger G; Thiede C
Cells Tissues Organs; 2008; 188(1-2):225-35. PubMed ID: 18303245
[TBL] [Abstract][Full Text] [Related]
5. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
Choudhary C; Olsen JV; Brandts C; Cox J; Reddy PN; Böhmer FD; Gerke V; Schmidt-Arras DE; Berdel WE; Müller-Tidow C; Mann M; Serve H
Mol Cell; 2009 Oct; 36(2):326-39. PubMed ID: 19854140
[TBL] [Abstract][Full Text] [Related]
6. Identification of protein tyrosine phosphatases associating with the PDGF receptor.
Markova B; Herrlich P; Rönnstrand L; Böhmer FD
Biochemistry; 2003 Mar; 42(9):2691-9. PubMed ID: 12614164
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of FLT3 mutations in pediatric non-promyelocytic acute myeloid leukemia.
Kang HJ; Hong SH; Kim IH; Park BK; Han KS; Cho HI; Shin HY; Ahn HS
Leuk Res; 2005 Jun; 29(6):617-23. PubMed ID: 15863200
[TBL] [Abstract][Full Text] [Related]
8. Pim-1 kinase phosphorylates and stabilizes 130 kDa FLT3 and promotes aberrant STAT5 signaling in acute myeloid leukemia with FLT3 internal tandem duplication.
Natarajan K; Xie Y; Burcu M; Linn DE; Qiu Y; Baer MR
PLoS One; 2013; 8(9):e74653. PubMed ID: 24040307
[TBL] [Abstract][Full Text] [Related]
9. FLT3/ITD mutation signaling includes suppression of SHP-1.
Chen P; Levis M; Brown P; Kim KT; Allebach J; Small D
J Biol Chem; 2005 Feb; 280(7):5361-9. PubMed ID: 15574429
[TBL] [Abstract][Full Text] [Related]
10. Simplified capillary electrophoresis detection of the Flt-3 internal tandem duplications and D835 point mutations in acute myeloid leukemia.
Chang TL; Salto-Tellez M; Kueh YK; Koay ES
Haematologica; 2003 Feb; 88(2):ELT04. PubMed ID: 12604435
[No Abstract] [Full Text] [Related]
11. Tyrosine phosphatase SHP-2 regulates IL-1 signaling in fibroblasts through focal adhesions.
Herrera Abreu MT; Wang Q; Vachon E; Suzuki T; Chow CW; Wang Y; Hong O; Villar J; McCulloch CA; Downey GP
J Cell Physiol; 2006 Apr; 207(1):132-43. PubMed ID: 16250012
[TBL] [Abstract][Full Text] [Related]
12. In control at the ER: PTP1B and the down-regulation of RTKs by dephosphorylation and endocytosis.
Stuible M; Tremblay ML
Trends Cell Biol; 2010 Nov; 20(11):672-9. PubMed ID: 20864346
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the activating mutations within the activation loop of leukemia targets Flt-3 and c-Kit based on protein homology modeling.
Torrent M; Rickert K; Pan BS; Sepp-Lorenzino L
J Mol Graph Model; 2004 Oct; 23(2):153-65. PubMed ID: 15363457
[TBL] [Abstract][Full Text] [Related]
14. Constitutively activated FLT3 phosphorylates BAD partially through pim-1.
Kim KT; Levis M; Small D
Br J Haematol; 2006 Sep; 134(5):500-9. PubMed ID: 16869825
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
Muranyi AL; Dedhar S; Hogge DE
Exp Hematol; 2009 Apr; 37(4):450-60. PubMed ID: 19302919
[TBL] [Abstract][Full Text] [Related]
16. Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner.
Mitina O; Warmuth M; Krause G; Hallek M; Obermeier A
Ann Hematol; 2007 Nov; 86(11):777-85. PubMed ID: 17668209
[TBL] [Abstract][Full Text] [Related]
17. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum.
Haj FG; Verveer PJ; Squire A; Neel BG; Bastiaens PI
Science; 2002 Mar; 295(5560):1708-11. PubMed ID: 11872838
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors.
Siendones E; Barbarroja N; Torres LA; Buendía P; Velasco F; Dorado G; Torres A; López-Pedrera C
Hematol Oncol; 2007 Mar; 25(1):30-7. PubMed ID: 17128418
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
20. A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
Masson K; Liu T; Khan R; Sun J; Rönnstrand L
Br J Haematol; 2009 Jul; 146(2):193-202. PubMed ID: 19438505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
